about
Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial functionAlterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor FluoxetineLactosylceramide contributes to mitochondrial dysfunction in diabetesIdentification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5Torpor induction in mammals: recent discoveries fueling new ideasEssential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury.Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death.Global changes in phospholipids identified by MALDI MS in rats with focal cerebral ischemiaDevelopmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis.Cigarette smoke increases cardiomyocyte ceramide accumulation and inhibits mitochondrial respiration.Oxidized phospholipids induce ceramide accumulation in RAW 264.7 macrophages: role of ceramide synthases.Lipid raft redox signaling: molecular mechanisms in health and disease.Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA.Changes in the metabolism of sphingolipids after subarachnoid hemorrhage.(R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria.Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury.Fetal asphyxia induces acute and persisting changes in the ceramide metabolism in rat brain.Cell biology. Ceramides--friend or foe in hypoxia?Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia.Lipid transport between the endoplasmic reticulum and mitochondria.Sphingolipids and mitochondrial apoptosis.The Role of Ceramide in the Pathogenesis of Alcoholic Liver Disease.Inhibition of neutral sphingomyelinase decreases elevated levels of nitrative and oxidative stress markers in liver ischemia-reperfusion injury.Neutral sphingomyelinase inhibition alleviates apoptosis, but not ER stress, in liver ischemia-reperfusion injury.Multiple sphingolipid abnormalities following cerebral microendothelial hypoxiaMitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle.Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury.Acute and chronic immunomodulatory changes in rat liver after fetal and perinatal asphyxia.Role of mitofusin 2 in the protective effect of breviscapine against hepatic ischemia/reperfusion injury in rats.Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic stroke.
P2860
Q26852356-80789A94-7497-4D3D-8C83-4B3B291F89D6Q28270227-C5419734-329D-44EC-8483-63D15A872B48Q28390671-D8F4BC86-7746-46D4-A9DA-F4C082EC36FFQ28590499-A54244F5-B78A-4434-94B6-DA376DB5F304Q28749655-9120AFD7-187E-4D4A-9E0A-1F2B25A18A33Q33676598-3DD1C6C2-78FD-4389-93D9-2C0AFE8402FDQ33986280-942FFAA5-5D95-4145-8D55-47A31B41D2E8Q34323295-D6F4DE97-C4D6-46EF-A0EB-92F1BDD59698Q34575828-A4A3123A-91F0-4800-B599-0D0CF3EA2F2EQ34586907-60309EA5-36D7-4404-A030-7931A138D283Q34921734-999D7CFA-ED26-4AC8-B59A-4AC4686308E7Q35101890-EA14481D-A2CF-4310-813C-1AAB34FB1FDCQ35107592-10CA7B43-FC5E-47F8-A82D-4E4D9ABF73B6Q35175609-446352F7-FF3C-40E8-B33E-A7EE176D8698Q35707937-96BB3D66-D86C-4D61-AEAD-C6585CD443D6Q35845455-75A4DCD9-2B74-49AC-94A6-BA4D9B39A7D1Q36920565-997333C0-A121-4327-8BAF-EDAA12F8660BQ37120912-EEF04111-5FD5-4322-8A42-21D15DFBDB13Q37765497-A22FFE6D-269A-4126-A5E5-EAEDACEADAE8Q38009932-D594B0FD-2264-48FA-BB94-A2D47D33D374Q38111617-954F8B1D-56BF-4DB4-AF38-6DE36DD9F876Q38332040-F505484B-C530-455E-BC24-6EC2EEC81ADCQ38618873-4E6B5A45-97B2-4A6B-8614-247852831963Q38881369-7BE54A91-87F0-4CB5-8271-F5A04296DCA9Q38917706-915AB173-CCF6-4406-B622-528C95A1E3C5Q38971853-0BF60214-C55E-4778-ACCB-92BD3DE3F232Q39090640-D64857F2-084D-4DA0-BD9F-1925447BC3AFQ46608425-41ED0543-C90E-4A35-AB85-A3E0CB6F2FBAQ50642610-64904D7B-2D3C-44FC-8E4E-F0E53C8E4FD7Q55263366-8F39DECB-0A07-4B6A-A51D-5FF47ABB97CAQ55281261-0461D338-FC48-4184-9BA7-003FE4803C31
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ceramide and mitochondria in ischemia/reperfusion.
@en
Ceramide and mitochondria in ischemia/reperfusion.
@nl
type
label
Ceramide and mitochondria in ischemia/reperfusion.
@en
Ceramide and mitochondria in ischemia/reperfusion.
@nl
prefLabel
Ceramide and mitochondria in ischemia/reperfusion.
@en
Ceramide and mitochondria in ischemia/reperfusion.
@nl
P2860
P1476
Ceramide and mitochondria in ischemia/reperfusion.
@en
P2093
Sergei A Novgorodov
Tatyana I Gudz
P2860
P304
P356
10.1097/FJC.0B013E31819B52D5
P577
2009-03-01T00:00:00Z